Moderna Gets MHRA Authorization for Updated COVID-19 Vaccine
For the first time in the UK, the updated vaccine, Spikevax JN.1, will also be available to purchase privately for those who are not eligible for the NHS Autumn vaccination program.
Moderna | 05/09/2024 | By Aishwarya
Moderna and Mitsubishi Tanabe Pharma to Promote mRNA Respiratory Vaccine in Japan
Moderna, Inc. has signed a joint agreement with Mitsubishi Tanabe Pharma regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including Moderna's COVID-19 vaccine, Spikevax.
Moderna | 15/07/2024 | By Aishwarya | 115
Global diseases treatment with mRNA to be researched by Moderna and IAVI together
Moderna and IAVI, a nonprofit scientific research organization, are teaming up to use mRNA to develop new therapies for a range of diseases like HIV / AIDS, Tuberculosis, anti-microbial-resistant enteric infection and COVID-19.
Moderna | 12/04/2022 | By Sudeep Soparkar | 433
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy